TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. 2014/1/10 MoneyDJ http://www.moneydj.com/KMDJ/News/NewsViewer.aspx?a=058f83d3-932f-4c49-8593-3f4d895f7c24#ixzz2qSZZmRmQ Chang Lisa 2021-02-17T13:53:31+00:00
